Levitee Labs Inc. entered into a letter of intent to acquire ACT Medical Inc for CAD 5.9 million on January 29, 2021. Out of total consideration to be paid, 65% of which will be payable in cash, and 35% of which will be payable in common shares. Levitee paid a non-refundable deposit of CAD 50,000. Under the transaction, Levitee will purchase ACT 6 clinics and 3 pharmacies, which offer addiction and pain management medical services as well as drug dispensing in Alberta. As of July 9, 2021, due diligence has not been completed and definitive agreement have not been entered into. On July 19, 2021, Levitee Labs received final approval from the Canadian Securities Exchange to list its common shares on the CSE. On July 23, 2021, Asset purchase agreement to acquire all material operating assets of ACT Medical Centres, Inc. comprised of a group of five (5) addiction and pain management clinics across Alberta. As of July 28, 2021, Levitee Labs Inc. completed the acquisition of all material operating assets of ACT Medical Centres Inc. for CAD 0.35 million. Levitee intends to integrate these clinics with its current assets in mental health and addiction treatment, as well as assets that are acquired by Levitee in the future. Transaction is expected to close by third quarter 2021. Levitee Labs Inc. (CNSX:LVT) acquired ACT Medical Centres Inc. for CAD 0.35 million on July 28, 2021. Levitee Labs Inc. (CNSX:LVT) completed the acquisition of ACT Medical Centres Inc. on July 28, 2021.